NEW YORK, Oct. 14, 2015 /PRNewswire/ -- Noninvasive prenatal testing (NIPT) is an advancement in the detection of fetal chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant woman. Since its introduction to clinical practice in 2011, NIPT has quickly spread across the globe. Hundreds of thousands of pregnant women have used these noninvasive prenatal tests since they appeared on the market in 2011. The global market for NIPT is growing rapidly; it has been projected to grow at a double digit growth rate during the period 2015 - 2020. The competition in the NIPT market landscape is fierce and the companies are aggressively looking to push their test volume.
Global - Non-Invasive Prenatal Testing (NIPT) Market Analysis: MaterniT21 PLUS is the most popular test in NIPT market but it is facing high competition from other tests and also from introduction of newer tests like informaSeq and VisibiliT prental tests. Harmony prenatal test and Verifi test are competing closely to grab a handsome share of the total NIPT market. Panorama test is anticipated to emerge as one of the leading test in the Global NIPT market by the year 2020. BambniTest and NIFTY tests are also looking to capture maximum pie of the Global NIPT market.
Global - Non-Invasive Prenatal Testing (NIPT) Volume Analysis: In the Global NIPT Test Volume, NIFTY Test captured the majority share followed by Harmony in the year 2014. MaterniT21 PLUS and BambniTest accounted for XXX% and XXX% share of the overall NIPT volume respectively in 2014. Panorama and Verifi test volume share is also expected to rise during the forecasting period. The newly introduced tests namely informaSeq and VisibiliT are likely to show double digit growth rate during the forecasting period.
iGATE RESEARCH report titled "Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume Analysis to 2020" is a 107 page report with 40 Figures and 13 Table. This report analyses the Global - Non-Invasive Prenatal Testing (NIPT) Market and Volume - Top 10 NIPT Test, Major Chromosomal Aneuploidies and their Incidence Rate, Major Deals in the NIPT landscape, NIPT Implementation in HICs and LMICs. Driving factors and Challenges for NIPT market.
The 10 NIPT Test covered in the report has been analyzed from 2 viewpoints:
1. NIPT Test Market Revenue (2012-2020)
2. NIPT Test Volume (2012 – 2020)
The 10 NIPT Test covered in the report are:
4. MaterniT21 PLUS
10. NIPD Test
The Major Chromosomal Aneuploidies and their Incidence Rate Covered in the report are:
1. Down Syndrome
2. Edwards Syndrome
3. Patau Syndrome
4. Turner Syndrome
5. Klinefelter Syndrome
6. Jacobs Syndrome
7. Triple X Syndrome
The report also covers NIPT Implementation in High Income Countries and Low – or- Middle Income Countries. The 3 issues for implementation covered are:
1. Clinical Issues
2. Ethical Issues
3. Legal and Regulatory Issues
Source of Information
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.
Read the full report: http://www.reportlinker.com/p03007686-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker reviews, finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
Intl: +1 339-368-6001